These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 828599)
1. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine. Yamamura Y; Azuma I; Sugimura K; Yamawaki M; Uemiya M Gan; 1976 Dec; 67(6):867-77. PubMed ID: 828599 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds. Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds. Azuma I; Sugimura K; Taniyama T; Yamawaki M; Yamamura Y Infect Immun; 1976 Jul; 14(1):18-27. PubMed ID: 820642 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs. Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs. Uemiya M; Saiki I; Kusama T; Azuma I; Yamamura Y Microbiol Immunol; 1979; 23(8):821-3. PubMed ID: 120487 [No Abstract] [Full Text] [Related]
7. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8. Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194 [TBL] [Abstract][Full Text] [Related]
8. Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides. Kotani S; Watanabe Y; Shimono T; Narita T; Kato K Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):302-19. PubMed ID: 126564 [TBL] [Abstract][Full Text] [Related]
9. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens. Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961 [TBL] [Abstract][Full Text] [Related]
10. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats. Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128 [TBL] [Abstract][Full Text] [Related]
11. Studies on the composition of adjuvants which selectively enhance delayed-type hypersensitivity to lipid conjugated protein antigens. Champlin R; Hunter RL J Immunol; 1975 Jan; 114(1 Pt 1):76-80. PubMed ID: 1089714 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice. Taniyama T; Azuma I; Yamamura Y Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834 [TBL] [Abstract][Full Text] [Related]
13. Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum. Kotani S; Watanabe Y; Shimono T; Kinoshita F; Narita T Biken J; 1975 Jun; 18(2):93-103. PubMed ID: 1180873 [TBL] [Abstract][Full Text] [Related]
14. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes. Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant and mitogenic activities of niacine derivatives and their NAD-analogs. Saiki I; Tono-oka S; Azuma I Int J Vitam Nutr Res; 1981; 51(3):239-46. PubMed ID: 6797979 [TBL] [Abstract][Full Text] [Related]
16. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules. Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and immunoadjuvant activities of the repeating, disaccharide-dipeptide unit of the bacterial, cell-wall peptidoglycan and of some carbohydrate analogs. Kiso M; Kaneda Y; Shimizu R; Hasegawa A; Azuma I Carbohydr Res; 1982 Jun; 104(2):253-69. PubMed ID: 7105067 [TBL] [Abstract][Full Text] [Related]
18. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine. Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186 [TBL] [Abstract][Full Text] [Related]
20. Relationship of anti-tuberculous protection to lung granuloma produced by intravenous injection of synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with or without specific antigens. Yamamoto K; Kakinuma M; Kato K; Okuyama H; Azuma I Immunology; 1980 Aug; 40(4):557-64. PubMed ID: 7000685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]